{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-Spillage-Incident-Management-of-IP-Biologicals”
},
“headline”: “SOP for Spillage and Incident Management of IP and Biologicals in Clinical Trials”,
“description”: “This SOP provides detailed procedures for managing spillage or incidents involving investigational products (IP) and biological materials during clinical trials, ensuring safety, accountability, and compliance with ICH GCP, FDA, EMA, CDSCO, and WHO standards.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Spillage and Incident Management of IP and Biologicals

Purpose

The purpose of this SOP is to outline clear procedures for the safe handling and management of spillage or incidents involving investigational products (IP) and biological materials in clinical trials. It ensures protection of staff, subjects, and the environment while maintaining proper documentation and regulatory compliance.

Scope

This SOP applies to all staff at clinical trial sites handling IP and biological materials, including investigators, pharmacists, nurses, coordinators, and laboratory personnel. It covers spillage during receipt, storage, preparation, dispensing, administration, or transportation of IPs and biologicals.

Responsibilities

• Principal Investigator (PI): Responsible for oversight of incident management and reporting to sponsor and regulatory authorities.
• Pharmacist/Study Nurse: Executes spill management procedures, ensures staff safety, and documents the incident.
• Study Coordinator: Maintains incident reports and files records in ISF and TMF.
• Sponsor/CRO: Reviews incident reports, assesses impact, and ensures regulatory reporting is completed.
• Quality Assurance Officer: Audits incident handling and verifies corrective actions.

Accountability

The PI is accountable for ensuring immediate and effective management of IP/biological spillage incidents. Sponsors are accountable for oversight and verification of compliance with reporting and corrective action requirements.

Procedure

1. Immediate Response
Alert all personnel and restrict access to the area.
Wear appropriate personal protective equipment (PPE).
Contain the spill using absorbent pads or spill kits.

2. Spill Cleanup
Collect spilled material safely using designated spill kits.
Dispose of contaminated materials as per hazardous waste regulations.
Decontaminate surfaces with appropriate disinfectant.

3. Medical Emergencies
If exposure occurs, provide first aid and medical treatment immediately.
Record incident in Exposure/Incident Report (Annexure-1).

4. Documentation
Complete Spillage Incident Report Form (Annexure-2).
Record batch number, subject ID (if applicable), and amount lost.
File records in ISF and TMF.

5. Reporting
Notify PI, sponsor, and QA immediately.
Report serious incidents to EC/IRB and regulatory authority if required.

6. Corrective and Preventive Actions (CAPA)
Conduct root cause analysis of incident.
Implement CAPA and document actions in CAPA Log (Annexure-3).

7. Archiving
Archive incident records and CAPA documentation for minimum 5 years post-trial or as per national regulations.

Abbreviations

• SOP: Standard Operating Procedure
• PI: Principal Investigator
• IP: Investigational Product
• CRO: Clinical Research Organization
• ISF: Investigator Site File
• TMF: Trial Master File
• PPE: Personal Protective Equipment
• QA: Quality Assurance
• CAPA: Corrective and Preventive Action

Documents

1. Exposure/Incident Report (Annexure-1)
2. Spillage Incident Report Form (Annexure-2)
3. CAPA Log (Annexure-3)

References

• ICH E6(R2) – Good Clinical Practice
• US FDA – Guidance on Handling of Investigational Products
• EMA Clinical Trial Regulation
• CDSCO Clinical Trial Rules, 2019
• WHO – Laboratory Biosafety and Biological Spill Response Guidelines

Version: 1.0

Approval Section

Annexures

Annexure-1: Exposure/Incident Report

Annexure-2: Spillage Incident Report Form

Annexure-3: CAPA Log

Revision History

For more SOPs visit: Pharma SOP